BofA Upgrades Andrx to 'Buy'

Analyst David Maris says the generic-drug maker is making the right moves to maximize its potential

Banc of America upgraded Andrx (ADRX ) to buy, from neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.